St. Vincent Hospital is a hospital in Indianapolis, Indiana, US. It is the flagship installation of St. Vincent Health which operates 22 facilities over 46 Indiana counties and is one of the largest ministries in the Catholic health care organization Ascension.

During the past decade, Ascension Saint Vincent Indianapolis Hospital conducted 53 clinical trials. In the 10-year time frame, 53 clinical trials started and 30 clinical trials were completed, i.e. on average, 56.6% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 23 clinical trials were completed. i.e. 95.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ascension Saint Vincent Indianapolis Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 55 trials, followed by "Children's Oncology Group" with 11 trials sponsored, "Bellerophon Pulse Technologies" with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ascension Saint Vincent Indianapolis Hospital" #1 collaborator was "NRG Oncology" with 17 trials as a collaborator, "National Cancer Institute (NCI)" with 13 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "Children's Oncology Group" with 3 trials as a collaborator and "North Central Cancer Treatment Group" with 3 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Ascension Saint Vincent Indianapolis Hospital" are "Recurrent Neuroblastoma" (11 trials), "Refractory Neuroblastoma" (9 trials), "Recurrent Hepatoblastoma" (8 trials), "Recurrent Langerhans Cell Histiocytosis" (8 trials) and "Recurrent Osteosarcoma" (8 trials). Many other conditions were trialed in "Ascension Saint Vincent Indianapolis Hospital" in a lesser frequency.

Most popular intervention types in "Ascension Saint Vincent Indianapolis Hospital" are "Drug" (65 trials), "Other" (49 trials), "Biological" (32 trials), "Procedure" (25 trials) and "Radiation" (15 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (32 trials), "Quality-of-Life Assessment" (18 trials), "Computed Tomography" (15 trials), "Cyclophosphamide" (15 trials) and "Questionnaire Administration" (15 trials). Other intervention names were less common.

The vast majority of trials in "Ascension Saint Vincent Indianapolis Hospital" are 56 trials for "All" genders and 20 trials for "Female" genders.

Currently, there are NaN active trials in "Ascension Saint Vincent Indianapolis Hospital". undefined are not yet recruiting, 23 are recruiting, 46 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Ascension Saint Vincent Indianapolis Hospital, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ascension Saint Vincent Indianapolis Hospital, 0 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 47 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".